OmniAb, Inc. (OABI) vs SOPHiA GENETICS S.A. (SOPH)
A side-by-side comparison of OmniAb, Inc. and SOPHiA GENETICS S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
OABI
OmniAb, Inc.
$4.35HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SOPH
SOPHiA GENETICS S.A.
$7.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — OABI vs SOPH
growth of $100 · dividends reinvested · last 5yOABI -49.6% (-12.8%/yr)SOPH -53.2% (-14.1%/yr)OABI compounded faster over this window
OABI SOPH
OABI vs SOPH: by the numbers
- •OABI is the larger company ($631M vs $619M market cap).
- •Both run net losses; SOPH's is the smaller (-93.86% vs -115.18% net margin).
- •SOPH grew revenue faster over the past five years (20.33% vs -4.31% CAGR).
Metrics side by side
Valuation
| Metric | OABI | SOPH |
|---|---|---|
| P/S ratio | 16.41 | 7.19 |
| P/B ratio | 2.42 | 7.45 |
Profitability
| Metric | OABI | SOPH |
|---|---|---|
| Gross margin | -18.17% | 66.63% |
| Operating margin | -383.15% | -85.01% |
| Net margin | -115.18% | -93.86% |
| ROE | -17.01% | -97.31% |
| ROIC | -17.48% | -49.73% |
Growth (annualized)
| Metric | OABI | SOPH |
|---|---|---|
| Revenue CAGR (5Y) | -4.31% | 20.33% |
| Total return CAGR (5Y) | -13.17% | -13.62% |
Frequently asked
- Which has grown faster, OABI or SOPH?
- Over the past five years, SOPH grew revenue faster — OABI at a -4.31% CAGR versus SOPH at 20.33%.
- How have OABI and SOPH total returns compared?
- Over the past 5 years, OABI delivered -13.17% and SOPH delivered -13.62% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
OmniAb ROESOPHiA GENETICS ROEOmniAb operating marginSOPHiA GENETICS operating marginOmniAb revenue growthSOPHiA GENETICS revenue growthOmniAb free cash flowSOPHiA GENETICS free cash flow
OmniAb & SOPHiA GENETICS appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.